Drug Type Small molecule drug |
Synonyms APX-NEXT |
Target |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors), NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoinflammatory disease | Preclinical | BE | Apaxen SAStartup | 01 Mar 2023 |